Shares of Nuburu, Inc. (NYSEAMERICAN: BURU) were halted on Friday at 11:28 a.m. EDT after plummeting 39.2% to $0.0727, with over 39 million shares changing hands. The trading halt, which occurred during the NYSE American core session, was flagged as 'unknown' by real-time halt trackers, though the catalyst is clearly the company's announcement of a best-efforts offering aimed at raising approximately $38 million in gross proceeds.
The offering, priced at $0.1555 per unit, represents a 30% premium over the July 15 close. However, the structure is complex: each unit consists of either common stock or a pre-funded warrant, paired with Series B preferred shares. This packaging makes direct price comparisons misleading, as the preferred component carries different rights. At the halt price of $0.0727, common shares traded at a 53.2% discount to the package price, underscoring the market's deep concern over dilution.
According to the final prospectus, the offering includes 117.4 million common shares and 127.0 million pre-funded warrants. Combined, these represent 244.4 million shares, or 98.1% of the pre-offer common share base of 249.0 million. If all pre-funded warrants are exercised, the total common share count would soar to approximately 493.4 million, before any conversion of the 733,853 Series B preferred shares. This near-doubling of shares outstanding is at the heart of investor alarm.
Adding to the concerns is the use of proceeds: 44.1% of the projected gross raise, or $16.75 million, is earmarked for debt repayment — specifically $15.5 million for a debenture and $1.25 million for Lyocon notes. The remaining funds, after fees, will go toward Tekne assurance, acquisitions, and working capital. The company also plans to pause its equity line for at least 90 days, with limited exceptions.
The offering is on a best-efforts basis, meaning there is no guarantee of full subscription. This uncertainty, combined with the potential for further dilution from preferred share conversion and pending Tekne clearance, elevates risk. Nuburu's first-quarter revenue was a mere $407,644, while cash stood at $8.27 million. The $38 million gross raise is equivalent to 93 times quarterly revenue and 4.6 times cash on hand, highlighting the massive scale relative to operations.
Nuburu's exchange listing is also under pressure. In February, the company warned that a sustained trade below $0.10 would trigger a halt and potential delisting. The stock's current price of $0.0727 is well below that threshold. Management reported that preliminary unaudited equity as of May 31 was significantly above $4 million, but the NYSE American has yet to confirm compliance, with a plan in effect through October 29.
Executive Chairman and co-CEO Alessandro Zamboni remarked on June 29 that 'dilution is not always negative when issuances are used to reduce debt.' However, the latest prospectus lays bare the extent of the burden on existing holders. With the new common shares nearly equaling the current base, investors are now facing a capital repair trade rather than a simple premium issue. Debt relief may offer long-term benefits, but the immediate dilution and exchange risk are severe.
